Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.17
-3.02 (-1.34%)
AAPL  274.16
-4.12 (-1.48%)
AMD  209.55
-1.23 (-0.58%)
BAC  55.57
+0.43 (0.78%)
GOOG  307.61
-2.91 (-0.94%)
META  640.00
-4.23 (-0.66%)
MSFT  472.80
-5.73 (-1.20%)
NVDA  175.55
+0.53 (0.30%)
ORCL  181.59
-8.38 (-4.41%)
TSLA  473.00
+14.04 (3.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.